Lauren Hayes
Vice President, Strategic Planning and Investment Analytics
Replay available
Ligand Pharmaceuticals Incorporated (LGND) Q3 2025 Earnings Call
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) Q3 2025 earnings conference call, held 2025-11-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Melanie Herman
Head of Investor Relations
Talith Kormanon
Analyst, Craig Callen
Chavo Espinoza
Chief Financial Officer
Trevor Allred
Analyst, Oppenheimer & Co.
Jared Momine
Analyst, Steeple Group
Sahil Dhingra
Analyst, RBC Capital Markets
Todd Davis
Chief Executive Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ligand Pharmaceuticals Incorporated.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.497 Welcome to Ligon third quarter 2025 earnings call. 00:00:04.497 -- 00:00:07.762 All lines have been placed on mute to prevent any background noise. 00:00:07.762 -- 00:00:11.527 After the speaker's remarks, there will be a question and answer session. 00:00:11.527 -- 00:00:15.352 If you would like to ask a question during this time, simply press the star followed 00:00:15.352 -- 00:00:17.856 by the number one on your telephone keypad. 00:00:17.856 -- 00:00:21.220 If you would like to withdraw your question, please press the star one again. 00:00:21.220 -- 00:00:25.646 Thank you. I would now like to turn the conference over to Melanie Herman. 00:00:25.646 -- 00:00:28.027 Please go ahead. 00:00:30.254 -- 00:00:35.340 Good morning, everyone, and welcome to Ligand's third quarter 2025 earnings call. 00:00:35.340 -- 00:00:39.244 During the call today, we will review the financial results we released earlier today 00:00:39.244 -- 00:00:44.130 and provide commentary on our partner pipeline and business development activity, followed 00:00:44.130 -- 00:00:48.475 by a question and answer session. Before we get started, I would like to point out that 00:00:48.475 -- 00:00:53.100 we will be discussing non-GAAP results, which excludes certain items such as stock-based 00:00:53.100 -- 00:00:58.326 compensation, amortization of intangible assets, amortization or impairment 00:00:58.326 -- 00:01:03.435 of financial assets, losses from derivative assets, and gain from the sale of the 00:01:03.435 -- 00:01:08.182 Paltos business, amongst others. I encourage you to review the reconciliation of these 00:01:08.182 -- 00:01:12.729 non-GAAP measures to their most directly comparable GAAP measures, which can be found 00:01:12.729 -- 00:01:15.753 in today'...